x_label	specimen_descriptor_fill	box_sample_count	Gene_Ensembl_ID	Gene_symbol	PMTL	Dataset	Disease	GTEx_tissue_subgroup	EFO	MONDO	GTEx_tissue_subgroup_UBERON	TPM_mean	TPM_sd	TPM_min	TPM_25th_percentile	TPM_median	TPM_75th_percentile	TPM_max
Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)	Pediatric Primary and Relapse Tumors	613	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TARGET	Acute Lymphoblastic Leukemia		EFO_0000220	MONDO_0004967		7.78	12.8	0.04	1.79	3.48	7.44	117.72
Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)	Pediatric Primary and Relapse Tumors	210	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TARGET	Acute Myeloid Leukemia		EFO_0000222	MONDO_0018874		0.49	0.75	0	0.11	0.25	0.51	5.21
Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 23)	Pediatric Primary and Relapse Tumors	23	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Adamantinomatous Craniopharyngioma		EFO_1000069	MONDO_0002787		1.32	0.64	0.14	0.77	1.44	1.84	2.27
Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 30)	Pediatric Primary and Relapse Tumors	30	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Atypical Teratoid Rhabdoid Tumor		EFO_1002008	MONDO_0020560		3.9	4.19	0.15	0.95	1.8	6.12	14.53
Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 4)	Pediatric Primary and Relapse Tumors	4	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Chordoma		Orphanet_178	MONDO_0008978		0.47	0.17	0.27	0.37	0.49	0.6	0.64
CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)	Pediatric Primary and Relapse Tumors	13	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	CNS Embryonal tumor		EFO_0005784	MONDO_0018843		20.94	22.46	0.41	2.28	14.75	28.31	64.13
Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)	Pediatric Primary and Relapse Tumors	13	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Craniopharyngioma		EFO_1000209	MONDO_0002787		1.29	3.09	0.16	0.26	0.39	0.62	11.52
Diffuse fibrillary astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 7)	Pediatric Primary and Relapse Tumors	7	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Diffuse fibrillary astrocytoma		Orphanet_251601	MONDO_0016688		3.05	3.15	0.5	1.3	1.98	3.41	9.48
Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)	Pediatric Primary and Relapse Tumors	9	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Diffuse intrinsic pontine glioma		EFO_1000026	MONDO_0006033		3.98	1.88	1.22	2.91	3.88	6.11	6.35
Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 72)	Pediatric Primary and Relapse Tumors	72	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Diffuse midline glioma		EFO_1000026	MONDO_0006033		7.61	8.98	0.36	2.53	4.38	9.64	59.85
Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 23)	Pediatric Primary and Relapse Tumors	23	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Dysembryoplastic neuroepithelial tumor		EFO_0005551	MONDO_0005505		4.69	3.25	0.47	1.73	4.37	6.93	11.74
Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)	Pediatric Primary and Relapse Tumors	6	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Embryonal tumor with multilayer rosettes		MONDO_0016715	MONDO_0016715		41.38	29.92	0.29	18.31	48.96	64.5	72.27
Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 88)	Pediatric Primary and Relapse Tumors	88	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Ependymoma		EFO_1000028	MONDO_0016698		1.31	1.41	0.02	0.48	0.76	1.59	7.9
Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)	Pediatric Primary and Relapse Tumors	10	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Ewing sarcoma		EFO_0000174	MONDO_0012817		8.11	7.47	0.75	2.26	6.76	9.91	23.04
Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 45)	Pediatric Primary and Relapse Tumors	45	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Ganglioglioma		EFO_0003094	MONDO_0016733		2.2	1.87	0.46	0.98	1.3	3	7.55
Ganglioneuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 45)	Pediatric Primary and Relapse Tumors	45	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	All Cohorts	Ganglioneuroblastoma		EFO_0000502	MONDO_0005035		44.51	60.21	0.31	2.36	12.09	71.48	226.22
Glial-neuronal tumor NOS  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 8)	Pediatric Primary and Relapse Tumors	8	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Glial-neuronal tumor NOS		MONDO_0016729	MONDO_0016729		3.96	2.45	1.02	1.96	4.21	5.32	7.88
Hemangioblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)	Pediatric Primary and Relapse Tumors	3	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Hemangioblastoma		MONDO_0016748	MONDO_0016748		0.57	0.43	0.25	0.33	0.41	0.74	1.06
High-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 122)	Pediatric Primary and Relapse Tumors	122	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	High-grade glioma/astrocytoma		MONDO_0016680	MONDO_0016680		9.96	17.36	0.15	2.08	4.78	10.05	135.87
Low-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 83)	Pediatric Primary and Relapse Tumors	83	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Low-grade glioma/astrocytoma		MONDO_0016685	MONDO_0016685		3.07	2.34	0.28	1.44	2.65	4.03	12.52
Malignant peripheral nerve sheath tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)	Pediatric Primary and Relapse Tumors	3	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Malignant peripheral nerve sheath tumor		EFO_0000760	MONDO_0017827		0.69	0.53	0.33	0.38	0.43	0.86	1.3
Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 118)	Pediatric Primary and Relapse Tumors	118	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Medulloblastoma		EFO_0002939	MONDO_0007959		27.21	18.23	1.74	15.47	23.63	32.39	101.39
Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 21)	Pediatric Primary and Relapse Tumors	21	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Meningioma		Orphanet_2495	MONDO_0016642		0.7	0.51	0.03	0.37	0.57	0.9	2.03
Metastatic secondary tumors  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 4)	Pediatric Primary and Relapse Tumors	4	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Metastatic secondary tumors		EFO_0009812	MONDO_0024883		9.04	16.81	0.18	0.29	0.88	9.63	34.24
Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 315)	Pediatric Primary and Relapse Tumors	315	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	All Cohorts	Neuroblastoma		EFO_0000621	MONDO_0005072		50.62	42.81	0.27	23.42	37.92	63.68	332.67
Neuroblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)	Pediatric Primary and Relapse Tumors	5	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Neuroblastoma		EFO_0000621	MONDO_0005072		12.77	11.41	0.27	0.95	16.72	22.11	23.81
Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)	Pediatric Primary and Relapse Tumors	137	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TARGET	Neuroblastoma		EFO_0000621	MONDO_0005072		79.74	49.79	1.85	43.22	70.02	111.43	332.67
Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)	Pediatric Primary and Relapse Tumors	16	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Neurofibroma/Plexiform		EFO_0000658	MONDO_0003304		0.49	0.4	0.08	0.23	0.4	0.64	1.65
Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)	Pediatric Primary and Relapse Tumors	3	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Oligodendroglioma		EFO_0000632	MONDO_0016695		1.48	1.01	0.32	1.14	1.95	2.06	2.18
Pilocytic astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 128)	Pediatric Primary and Relapse Tumors	128	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Pilocytic astrocytoma		MONDO_0016691	MONDO_0016691		3.11	1.77	0.04	1.8	2.71	4.21	9.55
Pleomorphic xanthoastrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 12)	Pediatric Primary and Relapse Tumors	12	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Pleomorphic xanthoastrocytoma		MONDO_0016690	MONDO_0016690		1.86	2.33	0.37	0.61	0.96	1.99	8.68
Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)	Pediatric Primary and Relapse Tumors	5	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Sarcoma		EFO_0000691	MONDO_0005089		1.61	2.1	0.17	0.52	0.65	1.44	5.27
Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)	Pediatric Primary and Relapse Tumors	16	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Schwannoma		EFO_0000693	MONDO_0002546		0.61	0.2	0.3	0.47	0.6	0.74	0.98
Subependymal Giant Cell Astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 12)	Pediatric Primary and Relapse Tumors	12	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Subependymal Giant Cell Astrocytoma		MONDO_0016693	MONDO_0016693		0.35	0.18	0.09	0.2	0.36	0.46	0.7
Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)	Pediatric Primary and Relapse Tumors	6	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	PBTA	Teratoma		MONDO_0002601	MONDO_0002601		2.34	3.07	0.3	0.5	0.81	2.9	8.1
Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)	Pediatric Primary and Relapse Tumors	129	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TARGET	Wilms tumor		MONDO_0006058	MONDO_0006058		6.43	3.54	0.2	3.53	6.12	8.94	17.93
Colon Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 289)	TCGA Primary and Relapse Tumors	289	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Colon Adenocarcinoma		EFO_1001949	MONDO_0002271		1.78	1.39	0.06	0.79	1.47	2.27	9.22
Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 165)	TCGA Primary and Relapse Tumors	165	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Glioblastoma Multiforme		EFO_0000519	MONDO_0018177		20.43	25.65	0.75	5.3	11.04	25.51	171.81
Hepatocellular Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 371)	TCGA Primary and Relapse Tumors	371	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Hepatocellular Carcinoma		EFO_0000182	MONDO_0007256		0.35	0.77	0	0.08	0.15	0.32	9.18
Low-grade glioma/astrocytoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 521)	TCGA Primary and Relapse Tumors	521	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Low-grade glioma/astrocytoma		MONDO_0016685	MONDO_0016685		19.4	16.36	0.97	9.27	15.46	24.96	129.29
Lung Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 512)	TCGA Primary and Relapse Tumors	512	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Lung Adenocarcinoma		EFO_0000571	MONDO_0005061		2.78	8.1	0.06	0.47	0.96	2.38	129.19
Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 378)	TCGA Primary and Relapse Tumors	378	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Ovarian Serous Cystadenocarcinoma		EFO_1000043	MONDO_0006046		3.06	4.58	0.08	0.8	1.59	3.31	44.87
Rectum Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 93)	TCGA Primary and Relapse Tumors	93	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Rectum Adenocarcinoma		EFO_0005631	MONDO_0002169		1.72	1.36	0.26	0.87	1.22	2.13	6.32
Sarcoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 261)	TCGA Primary and Relapse Tumors	261	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Sarcoma		EFO_0000691	MONDO_0005089		4.82	6.25	0.15	1.3	2.63	5.94	51.12
Uterine Corpus Endometrial Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 179)	TCGA Primary and Relapse Tumors	179	ENSG00000213420	GPC2	Relevant Molecular Target (PMTL version 1.1)	TCGA	Uterine Corpus Endometrial Carcinoma		EFO_0007532	MONDO_0000553		6.74	8.95	0.1	1.38	3.75	8.45	69.48
